Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
AI-Focused Drug Discovery Stock RXRX Was Down 14% Last Week - Here's Why
August 25, 2025
Tickers
ABCL
ABSI
JNJ
RLAY
Tags
RLAY
Market News
ABCL
From
TalkMarkets
Short Report: Viking Therapeutics Short Interest At 5-Year High After VK273 Data
August 24, 2025
Tickers
MLTX
NGNE
SMR
VKTX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Can CRISPR Therapeutics’ Build On Gene-Editing Treatments?
August 22, 2025
Tickers
CRSP
Tags
Market News
CRSP
Pharma/Biotech
From
TalkMarkets
These 10 Biotech Companies Are Researching 9 Different Psychedelic-Based Substances
August 22, 2025
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
Market News
ATAI
Pharma/Biotech
From
TalkMarkets
'Big 5" Psychedelic-Based Biotech Stocks Up 34% YTD
August 19, 2025
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
MNMD
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Wall Street Is Now Dumping Its Junk On The Regular Investor
August 17, 2025
Tickers
ABBV
BITCOMP
BLSH
BRK-A
Tags
NVO
SPY
NVDA
From
TalkMarkets
AI-Focused Drug Discovery Stocks Declined 6%, On Average, Last Week - Here's Why
August 11, 2025
Tickers
ABCL
ABSI
RLAY
RXRX
Tags
RXRX
ABSI
Market News
From
TalkMarkets
ETFs In Focus On Eli Lilly's Solid Q2 Earnings, Weak Obesity Data
August 09, 2025
Tickers
IHE
LLY
MEDI
MEDX
Tags
Healthcare
MEDX
LLY
From
TalkMarkets
Pfizer Beats Expectations In Q2 2025, Raises EPS Guidance
August 05, 2025
Tickers
PFE
Tags
Pharma/Biotech
PFE
Market News
From
TalkMarkets
3 Of The 5 Stocks In Our AI-Focused Drug Discovery Portfolio Were Up Significantly Last Week - Here's Why
July 23, 2025
Tickers
ABCL
ABSI
RLAY
RXRX
Tags
ABCL
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Why Are Healthcare Stocks Underperforming The Market?
July 23, 2025
Tickers
ARKG
IHF
MRK
UNH
Tags
ETFs
UNH
IHF
From
TalkMarkets
Moderna’s Shares Gain In Premarket As New Flu Shot Shows Promising Results
June 30, 2025
Tickers
MRNA
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Dividend Stock Analysis: Amgen, Inc.
June 27, 2025
Tickers
AMGN
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Galectin Therapeutics Is Undervalued And With Short Squeeze Underway
June 20, 2025
Tickers
GALT
Tags
GALT
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Recursion Pharmaceuticals Went Down 10% Week-Ending June 13th - Here's Why
June 16, 2025
Tickers
RXRX
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Update: Abcellera Biologics Now Up 58% MTD
June 15, 2025
Tickers
ABCL
Tags
Pharma/Biotech
Stocks / Equities
ABCL
From
TalkMarkets
AI-Focused Drug Discovery Company, AbCellera, Up 21% W/e June 6th
June 11, 2025
Tickers
ABCL
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
AI-Focused Recursion Pharmaceuticals Stock Jumped 31% Last Week; Here's Why
June 11, 2025
Tickers
RXRX
Tags
Stocks / Equities
Pharma/Biotech
RXRX
From
TalkMarkets
The MunAIMarket AI-Focused Drug Discovery Stock Portfolio Has Flipped: Down 17% In May; Up 16% Last Week
June 09, 2025
Tickers
ABCL
ABSI
RLAY
RXRX
Tags
SDGR
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
3 Medical Instruments Stocks Winning Big With GenAI Amid Global Gloom
June 08, 2025
Tickers
ANGO
ITGR
PEN
Tags
PEN
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
CYDY: This Penny Stock Keeps Looking Better Coming Into Summer
June 02, 2025
Tickers
CYDY
Tags
Market News
Healthcare
CYDY
From
TalkMarkets
Why Is Moderna’s Stock Gaining In Premarket Trading Today?
June 02, 2025
Tickers
MRNA
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
3 Stocks Targeting Weight Loss Market With Cannabinoid-Based Therapies
May 24, 2025
Tickers
CRBP
LLY
NVO
SKYE
Tags
CRBP
Market News
Healthcare
From
TalkMarkets
SenesTech Remains Undervalued With Increasing Revenues And Global Product Distribution
May 20, 2025
Tickers
AMZN
COST
SNES
TSCO
Tags
COST
Consumer Goods
Stocks / Equities
From
TalkMarkets
Implications Of New FDA Leadership In The Biotechnology Industry
May 09, 2025
Tickers
CAPR
Tags
CAPR
Market News
Stocks / Equities
From
TalkMarkets
A Look At Pharma ETFs After Strong Q1 Earnings
May 08, 2025
Tickers
FTXH
IHE
PJP
PPH
Tags
Market News
PPH
IHE
From
TalkMarkets
How To Trade Cannabis Flower Globally: A Story Of Capital
May 02, 2025
Tags
Market News
Healthcare
Pharma/Biotech
From
TalkMarkets
Pfizer Reports Q1 2025: Revenue Down 8% Y/Y
April 29, 2025
Tickers
PFE
Tags
PFE
Market News
Pharma/Biotech
From
TalkMarkets
SenesTech's Big Play On Small Pests
April 17, 2025
Tickers
AMZN
SNES
TSCO
WMT
Tags
Market News
Capital & Industrial Goods
Basic Materials / Commodities
From
TalkMarkets
Is It A Good Time To Trade Small Cap Biotech Stocks? - 3 Steps To Consider
April 07, 2025
Tickers
XBI
Tags
Stocks / Equities
Pharma/Biotech
ETFs
From
TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.